Related Experiment Video
Updated: May 6, 2026

09:03
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
9.2K
Angiogenesis is prognostically important in vertical growth phase melanomas
O Straume1, H B Salvesen, L A Akslen
1Department of Pathology, The Gade Institute, Haukeland Hospital, N-5021 Bergen, Norway.
International Journal of Oncology
|July 31, 1999
Summary
Microvessel density (MVD) is linked to poorer survival in aggressive melanomas. This study found higher MVD correlates with larger tumors and ulceration, indicating its prognostic value.
Area of Science:
- Oncology
- Pathology
- Cancer Research
Background:
- Microvessel density (MVD) is an established prognostic marker in various human cancers.
- Understanding MVD's role in melanoma progression is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the association between microvessel density and patient survival in vertical growth phase melanomas.
- To determine if MVD is a significant prognostic factor in aggressive melanoma.
Main Methods:
- Immunohistochemical staining for factor-VIII related antigen was performed on 102 vertical growth phase melanoma samples.
- Microvessels were quantified in hot spot areas to determine MVD.
- Statistical analysis was used to correlate MVD with clinicopathologic features and patient survival.
Main Results:
- Increased MVD was significantly associated with larger histologic tumor diameter (p=0.006) and tumor ulceration (p=0.04).
- High microvessel density was significantly related to decreased patient survival (p=0.04).
- MVD showed borderline significance (p=0.10) in the multivariate survival model.
Conclusions:
- Microvessel density is an important prognostic indicator in aggressive vertical growth phase melanomas.
- Elevated MVD suggests a more aggressive tumor phenotype and poorer patient prognosis.
- Further research into MVD as a therapeutic target in melanoma is warranted.
Related Concept Videos
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K

